Journal of breast cancer therapy

These are journals that are and will I read =

Author(s)Article

Garrett, Thomas J.; Vahdat, Linda T.; Kinne, David W.Systemic adjuvant therapy of breast cancer

Disaia, Philip J.Estrogen replacement therapy for the breast cancer survivor: A reappraisal

Miller, Steven R.; Mondry, Tammy; Reed, Jennifer S.; Findley, Andrew; Johnstone, Peter A.S.Delayed cellulitis associated with conservative therapy for breast cancer

Taber, Scott W.; Fingar, Victor H.; Wieman, T. JefferyPhotodynamic therapy for palliation of chest wall recurrence in patients with breast cancer

Vicini, Frank; Kini, Vijay R.; Chen, Peter; Horwitz, Eric; Gustafson, Gary; Benitez, Pamela; Edmundson, Greg; Goldstein, Neal; McCarthy, Kevin; Martinez, AlvaroIrradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy

Saimura, Michiyo; Fukutomi, Takashi; Tsuda, Hitoshi; Sato, Hiroshi; Miyamoto, Kazuaki; Akashi-Tanaka, Sadako; Nanasawa, TakeshiPrognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: Analysis of clinicopathological prognostic factor

Gocheva, Lilia; Todorov, Jordan; Danon, SamuelTolerance of half-body irradiation as systemic therapy for patients with locally advanced breast cancer

Ingemar Persson; Erik Thurfjell; Reinhold Bergström; Lars HolmbergHormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

Sergio Dias; Hilary Thomas; Frances BalkwillMultiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model

Axel Hoos; Hedwig H. Hepp; Sepp Kaul; Thorsten Ahlert; Gunther Bastert; Diethelm WallwienerTelomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer

Pascal Bonnier; Frédéric Bessenay; Annie J. Sasco; Bassodeo Beedassy; Christiane Lejeune; Sylvie Romain; Colette Charpin; Lucien Piana; Pierre-Marie MartinImpact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer

Cecilia Magnusson; John A. Baron; Nestor Correia; Reinhold Bergström; Hans-Olov Adami; Ingemar PerssonBreast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

Frances S. Kenny; Sarah E. Pinder; Ian O. Ellis; Julia M.W. Gee; Robert I. Nicholson; Richard P. Bryce; John F.R. RobertsonGamma linolenic acid with tamoxifen as primary therapy in breast cancer

Timothy D. Shafman; Seth Levitz; Asa J. Nixon; Lor-Anne Gibans; Kim E. Nichols; Daphne W. Bell; Chikashi Ishioka; Kurt J. Isselbacher; Rebecca Gelman; Judy Garber; Jay R. Harris; Daniel A. HaberPrevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor

Stephen F. SenerBreast cancer in older women: Screening and selection of locoregional therapy

Malcolm M. Bilimoria; V. Craig JordanIs it time to develop an optimal endocrine therapy for premenopausal patients with axillary node positive and negative breast cancer?

Janardan D. KhandekarRecommendations on follow-up of breast cancer patients following primary therapy

S.E. Dunn; J.V. Torres; N. Nihei; J.C. BarrettThe insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy

David W. Kissane; Sidney Bloch; Patricia Miach; Graeme C. Smith; Ann Seddon; Nicholas KeksCognitive-Existential Group Therapy for Patients with Primary Breast Cancer — Techniques and Themes

William Breitbart; Ann Cull; Donna GreenbergClinical update: Impact of Adjuvant Therapy on Quality of Life in Women with Node Positive Operable Breast Cancer. Hurny, C., Bernhard, J., Coates, A.S., Castiglione-Gertsch, M., Peterson, H.F. et al. for the International Breast Cancer Study Group (1996) 347, No. 9011, 1279–1284.

A.J. Cunningham; C.V.I. Edmonds; G.P. Jenkins; H. Pollack; G.A. Lockwood; D. WarrA randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer

Claire V.I. Edmonds; Gina A. Lockwood; Alastair J. CunninghamPsychological response to long term group therapy: a randomized trial with metastatic breast cancer patients

Sarah Edelman; David R. Bell; Antony D. KidmanA group cognitive behaviour therapy programme with metastatic breast cancer patients

James Majeski; R. Marshall Austin; Richard H. FitzgeraldCutaneous angiosarcoma in an irradiated breast after breast conservation therapy for cancer: Association with chronic breast lymphedema

John De Csepel; Paul I. Tartter; Csaba GajdosWhen not to give radiation therapy after breast conservation surgery for breast cancer

Albert Segaloff; Douglas Gordon; Benjamin N. Horwitt; Joseph V. Schlosser; Paul J. MurisonHormonal therapy in cancer of the breast. I. The effect of testosterone propionate therapy on clinical course and hormonal excretion

Albert Segaloff; Douglas Gordon; Benjamin N. Horwitt; Joseph V. Schlosser; Paul J. MurisonHormonal therapy in cancer of the breast. II. Effect of methylandrostenediol on clinical course and hormonal excretion

Douglas Gordon; Benjamin N. Horwitt; Albert Segaloff; Paul J. Murison; Joseph V. SchlosserHormonal therapy in cancer of the breast. III. Effect of progesterone on clinical course and hormonal excretion

Albert Segaloff; Benjamin N. Horwitt; Douglas Gordon; Paul J. Murison; Joseph V. SchlosserHormonal therapy in cancer of the breast. IV. Effect of androstenediol on clinical course and hormonal excretion

Albert Segaloff; Benjamin N. Horwitt; Ralph A. Carabasi; Paul J. Murison; Joseph V. SchlosserHormonal therapy in cancer of the breast. V. The effect of methyltestosterone on clinical course and hormonal excretion

Albert Segaloff; Ralph Carabasi; Benjamin N. Horwitt; Joseph V. Schlosser; Paul J. MurisonHormonal therapy in cancer of the breast. VI. Effect of ACTH and cortisone on clinical course and hormonal excretion

Albert Segaloff; Douglas Gordon; Ralph A. Carabasi; Benjamin N. Horwitt; Joseph V. Schlosser; Paul J. MurisonHormonal therapy in cancer of the breast. VII. Effect of conjugated estrogens (equine) on clinical course and hormonal excretion

Albert Segaloff; Benjamin N. Horwitt; Ralph A. Cakabasi; Path J. Murison; Joskph V. Scht. OsserHormonal therapy in cancer of the breast. VIII. The effect of dihydrotestosterone (Androstanolone) on clinical course and hormonal excretion

Albert Segaloff; Douglas Gordon; Benjamin N. Horwitt; Paul J. Murison; Joseph V. SchlosserHormonal therapy in cancer of the breast. IX. The effect of androstanedione therapy on clinical course and hormonal excretion

Albert Segaloff; Douglas L. Gordon; Benjamin N. Horwitt; Paul J. Murison; Joseph V. SchlosserHormonal therapy in cancer of the breast. X. The effect of vinyltestosterone therapy on clinical course and hormonal excretion

B. J. Kennedy; Rita M. Kelley; George White; Ira T. NathansonSurgery as an adjunct to hormone therapy of breast cancer

Albert Segaloff; Douglas L. Gordon; C. Y. Bowers; Joseph V. Schlosser; Paul J. MurisonHormonal therapy in cancer of the breast XI. The effect of dehydroepiandrosterone on clinical course and hormonal excretion

Albert Segaloff; C. Y. Bowers; Douglas L. Gordon; Joseph V. Schlosser; Paul J. MurisonHormonal therapy in cancer of the breast XII. The effect of etiocholanolone therapy on clinical course and hormonal excretion

Albert Segaloff; C. Y. Bowers; Edward L. Rongone; Paul J. Murison; Joseph V. SchlosserHormonal therapy in cancer of the breast, XIII. The effect of 9?-fluoro-17?-methyl-?4-androsten-3-one-11?,17?-diol (fluoxymesterone) therapy on clinical course and hormonal excretion

A. Segaloff; C. Y. Bowers; E. L. Rongone; P. J. MurisonHormonal therapy in cancer of the breast. XIV. The effect of 19-nortestosterone propionate therapy on clinical course and hormonal excretion

Norman TrevesThe treatment of cancer, especially inoperable cancer, of the male breast by ablative surgey (orchiectomy, adrenalectomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids). An analysis of 42 patients

Albert Segaloff; C. Y. Bowers; E. L. Rongone; P. J. MurisonHormonal therapy in cancer of the breast. XV. Effect of epitestosterone propionate on clinical course and hormonal excretion

A. Segaloff; J. B. Weeth; E. L. Rongone; P. J. Murison; C. Y. BowersHormonal therapy in cancer of the breast. XVI. The effect of ?1-testololactone on clinical course and hormonal excretion

William J. Emerson; B. J. Kennedy; Edgar B. TaftCorrelation of histological alterations in breast cancer with response to hormone therapy

Albert Segaloff; J. B. Weeth; E. L. Rongone; C. Y. BowersHormonal therapy in cancer of the breast. XVII. The effect of androsterone on clinical course and hormonal excretion

Albert Segaloff; J. B. Weeth; Kenneth K. Meyer; E. L. Rongone; M. E. G. CuninghamHormonal therapy in cancer of the breast. XIX. Effect of oral administration of ?1-testololactone on clinical course and hormonal excretion

Albert Segaloff; Kenneth K. Meyer; E. L. Rongone; J. B. Weeth; M. E. G. CuninghamHormonal therapy in cancer of the breast. XX. Effect of testololactone or testosterone propionate on clinical course and hormonal excretion

Herbert Volk; Solomon Ciprut; George EscherHormonal therapy in advanced breast cancer. II. Effect of oral 11?-hydroxy-17?-methyltestosterone compared with fluoxymesterone on clinical course and its effect on metabolism of nitrogen and selected electrolytes

Albert Segaloff; Kenneth K. Meyer; John B. Weeth; Edward L. Rongone; Margaret CuninghamHormonal therapy in cancer of the breast. XXI. Effect of 2a-methyl-5a-dihydro-testololactone on clinical course and hormonal excretion

R. W. Tallky; M. J. Brennan; V. K. Vaitkevicius; V. L. BeckettComparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression—an index of tumor therapy evaluation

Albert Segaloff; Margaret Cuningham; John B. Weeth; Edward L. Rongone; Kenneth K. MeyerHormonal therapy in cancer of the breast. XXII. Effect of 17?-methyl-5?-dihydrotestosterone on clinical course and hormonal excretion

Edward F. Lewison; Frances H. Trimble; John L. Grow; Teruo MasukawaResults of combined hormone therapy in advanced breast cancer

Herbert Volk; Charles J. Foley; Louis J. Sanfilippo; George C. EscherHormonal therapy in advanced breast cancer. III. Effect of 6?-dibromomethylene testosterone propionate compared with that of 2?-methyl dihydrotestosterone propionate on clinical course and metabolism of selected serum electrolytes

Albert Segaloff; John B. Weeth; Margaret Cuningham; Kenneth K. MeyerHormonal therapy in cancer of the breast. XXIII. Effect of 7?-methyl-19-nortestosterone acetate and testosterone propionate on clinical course and hormonal excretion

B. J. Kennedy; John H. BrownCombined estrogenic and androgenic hormone therapy in advanced breast cancer

B. J. KennedyHormone therapy for advanced breast cancer

K. W. Zimmerman; E. D. Montague; G. H. FletcherFrequency, anatomical distribution and management of local recurrences after definitive therapy for breast cancer

B. J. Kennedy; Mary LowmanAlteration of iron metabolism during androgen therapy of advanced breast cancer

Ruth GuttmannRadiotherapy in locally advanced cancer of the breast. Adjunct to standard therapy

Fred J. AnsfieldChemotherapy in primary therapy of cancer of the breast

Albert Segaloff; Margaret Cuningham; B. F. Rice; J. B. WeethHormonal therapy in cancer of the breast. XXIV. Effect of corticosterone or medroxyprogesterone acetate on clinical course and hormonal excretion

Basil A. StollVaginal cytology as an aid to hormone therapy in postmenopausal cancer of the breast

William E. PowersBreast cancer—Preoperative and postoperative radiation therapy

B. J. KennedyHormone therapy in inoperable breast cancer

Robert E. FechnerBreast cancer during oral contraceptive therapy

Joseph H. Farrow; Alfred A. Fracchia; Guy F. Robbins; El CastroSimple excision or biopsy plus radiation therapy as the primary treatment for potentially curable cancer of the breast

Anthony J. Piro; Richard E. Wilson; Hans B. NevinnyCyclophosphamide therapy in patients with advancing breast cancer following adrenalectomy and 5-fluorouracil

Basil A. StollThe thermoprofile as an early indicator of breast cancer response to hormonal therapy

Mary Louise MeurkDosimetric considerations in radiation therapy of cancer of the breast

David L. Ahmann; Richard G. Hahn; Harry F. BiselDisseminated breast cancer: Evaluation of hormonal therapy utilizing stilbestrol and medrogestone (AY-62022) singly and in combination

Albert SegaloffHormonal therapy of breast cancer

Bernard FisherSurgical adjuvant therapy for breast cancer

Edwin D. Savlov; James L. Wittliff; Russell Hilf; Thomas C. HallCorrelations between certain biochemical properties of breast cancer and response to therapy: A preliminary report

Hugh L. Davis Jr.; Guillermo Ramirez; Richard A. Ellerby; Fred J. AnsfieldFive-drug therapy in advanced breast cancer. Factors Influencing Toxicity and Response

Ira S. Goldenberg; Nell Sedransk; Herbert Volk; Albert Segaloff; Rita M. Kelley; Carleton R. HainesCombined androgen and antimetabolite therapy of advanced female breast cancer A report of the cooperative breast cancer group

Kurt W. Brunner; Roland W. Sonntag; Georg Martz; Hans Jörg Senn; Paul Obrecht; Pierre AlbertoA controlled study in the use of combined drug therapy for metastatic breast cancer

Richard W. Nesto; Blake Cady; Richard A. Oberfield; Artemis G. Pazianos; Ferdinand A. SalzmanRebound response after estrogen therapy for metastatic breast cancer

Leonard R. Prosnitz; Ira S. Goldenberg; R. Andrew Packard; Martin B. Levene; Jay Harris; Samuel Hellman; Paul E. Wallner; Luther W. Brady; Carl M. Mansfield; Simon KramerRadiation therapy as initial treatment for early stage cancer of the breast wiithout mastectomy

A. RaventosClinical trials of adjuvant radiation therapy for breast cancer

J. L. Hayward; P. P. Carbone; J-C Heuson; S. Kumaoka; A. Segaloff; R. D. RubensAssessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

J. C. Heuson; E. Longeval; W. H. Mattheiem; M. C. Deboel; R. J. Sylvester; G. LeclercqSignificance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer

Luther W. Brady; Gilbert H. Fletcher; Seymour H. LevittCancer of the breast: The role of radiation therapy after mastectomy

K. W. Brunner; R. W. Sonntag; P. Alberto; H. J. Senn; G. Martz; P. Obrecht; P. MauriceCombined chemo- and hormonal therapy in advanced breast cancer

Takuma Nemoto; Dutzu Rosner; Romeo Diaz; Dr. Thomas Dao; Robert Sponzo; Thomas Cunningham; John Horton; Richard SimonCombination chemotherapy for metastatic breast cancer. Comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy

H. C. Falkson; J. J. van der Watt; M. A. Portugal; M. J. Pitout; Dr. G. FalksonCarcinoembryonic antigen in patients with breast cancer. An adjunctive tool to monitor response and therapy

Robert D. Rubens; Richard H. J. Begent; Robert K. Knight; Sheila A. Sexton; John L. HaywardCombined cytotoxic and progestogen therapy for advanced breast cancer

Marjorie Perloff; Ronald D. Hart; James F. HollandVinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy

Dr. Gilber H. Friedell; A report of the primary therapy of breast cancer study groupIdentification of breast cancer patients with high risk of early recurrence after radical mastectomy. II. Clinical and pathological correlations

Richard E. Lloyd; Stephen E. Jones; Sydney E. SalmonComparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer

Dr. Bellarmine V. Lawrence; Allan Lipton; Harold A. Harvey; Richard J. Santen; Samuel A. Wells JR.; Charles E. Cox; Deborah S. White; Emma K. SmartInfluence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy

Kirby I. Bland; Jerry B. Buchanan; Barbara F. Weisberg; Terry A. Hagan; Sr. Laman A. GrayThe effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns

Sewa S. Legha; Aman U. Buzdar; Terry L. Smith; Kenneth D. Swenerton; Gabriel N. Hortobagyi; George R. BlumenscheinResponse to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy

Bernard Fisher; Carol Redmond; Edwin R. Fisher; Participating NSABP InvestigatorsThe contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings

Florence C. H. ChuRadiation therapy in the management of locally advanced and disseminated breast cancer

J. Alexieva-Figusch; H. A. van Gilse; W. C. J. Hop; C. H. Phoa; J. Blonk-v. d. Wijst; R. E. TreurnietProgestin therapy in advanced breast cancer: Megestrol acetate—an evaluation of 160 treated cases

Charles A. Hubay; Olof H. Pearson; James S. Marshall; Robert S. Rhodes; Sara M. Debanne; Judah Rosenblatt; Edward G. Mansour; Robert E. Hermann; James C. Jones; William J. Flynn; Charles Eckert; William L McGuireAdjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial

Andrea Manni; Baha'Uddin Arafah; Olof H. PearsonEstrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

R. D. Rubens; J. L. HaywardEstrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer

Peter C. M. Young; Clarence E. Ehrlich; Lawrence H. EinhornRelationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer

David T. Kiang; Daniel H. Frenning; Juliette Gay; Anne I. Goldman; B. J. KennedyCombination therapy of hormone and cytotoxic agents in advanced breast cancer